The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Daptomycin Hospira

Pfizer Europe MA EEIGEU/1/17/1175/003-004

Main Information

Trade NameDaptomycin Hospira
Active SubstancesDaptomycin
Dosage FormPowder for solution for injection/infusion
Licence HolderPfizer Europe MA EEIG
Licence NumberEU/1/17/1175/003-004

Group Information

ATC CodeJ01XX Other antibacterials
J01XX09 daptomycin


License statusAuthorised
Licence Issued22/03/2017
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusUnknown


Summary of Product CharacteristicsSearch EMA website
Package LeafletSearch EMA website
Public Assessment ReportSearch EMA website
« Back